parp inhibitors for ovarian cancer
Published 5 years ago • 459 plays • Length 3:45Download video MP4
Download video MP3
Similar videos
-
1:38
updates in parp inhibition for ovarian cancer
-
1:22
overcoming resistance to parp inhibition in ovarian cancer
-
0:46
parp inhibitor rechallenging in ovarian cancer
-
3:09
the promising potential of parp inhibitors in ovarian cancer
-
2:38
assessing the role of parp inhibitors and immunotherapy in ovarian cancer
-
6:14
standard of care and progress with parp inhibitors for ovarian cancer
-
1:24
innovations in ovarian cancer treatment: parp inhibitors
-
2:30
do icis with parp inhibitors have a role in treating ovarian cancer?
-
0:45
evaluating future use of parp inhibitors in neoadjuvant therapy for ovarian cancer
-
2:58
standard of care updates in ovarian cancer: parp inhibitors
-
2:11
long-term benefit from 1l maintenance parp inhibitors in ovarian cancer
-
59:14
parp inhibitors in ovarian cancer: clinical updates from sgo 2023
-
3:58
the potential of parp inhibitors in ovarian cancer: paola-1, prima & velia
-
1:27
parp inhibition improves outcomes in patients with brca-mutated ovarian cancer
-
4:06
the promise of parp inhibitors and their emerging role in ovarian cancer
-
58:44
what’s new with parp inhibitors and ovarian cancer?
-
3:05
an overview of parp inhibitors in ovarian cancer
-
1:47
dr. liu on parp inhibitors in recurrent ovarian cancer
-
34:17
parp inhibitors for the treatment of ovarian cancer - gottfried konecny, md | uclamdchat